Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients.
about
Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreasNeuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewNon-functioning pancreatic neuroendocrine tumors: Surgery or observation?Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center.Characterization of single lesion nonfunctioning pancreatic neuroendocrine carcinoma via computed tomographyClinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in ChinaManagement Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).Therapy for metastatic pancreatic neuroendocrine tumors.Practical management and treatment of pancreatic neuroendocrine tumors.Pancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesionsClinicopathological features of small nonfunctioning pancreatic neuroendocrine tumorsTumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors.Multivisceral resection of pancreatic neuroendocrine tumours: a report of two casesBehavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors.Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine TumorsKi-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms.Factors related to long-term survival in patients affected by well-differentiated endocrine tumors of the pancreas.Surgical treatment and clinical outcome of nonfunctional pancreatic neuroendocrine tumors: a 14-year experience from one single center.Pancreatic neuroendocrine tumor with metastasis to the spleen: a case report.Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine TumorsResection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors.Pancreatic Neuroendocrine Tumors: an Update.Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors.Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.Genetic polymorphisms of interleukin 1β gene and sporadic pancreatic neuroendocrine tumors susceptibility.A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survivalApplications of a novel tumor-grading-metastasis staging system for pancreatic neuroendocrine tumors: An analysis of surgical patients from a Chinese institution.Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypesKmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.Surgical management of pancreatic neuroendocrine tumors.Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation.Current understanding of the molecular biology of pancreatic neuroendocrine tumors.Advancements in pancreatic neuroendocrine tumors.Laparoscopic resection of pancreatic neuroendocrine tumors.AACE/ACE disease state clinical review: pancreatic neuroendocrine incidentalomas.
P2860
Q26752757-FADFFB9B-F730-48FD-A888-8ADB1507A563Q26768483-CC658157-6E76-4726-96E7-C611428D0D68Q33573118-15835528-8B3D-4AFC-9A39-0614AAF5DC1AQ33597784-6B62F00F-E4E7-4332-93FE-8276D8A07482Q33598039-CCA117FA-BF80-471B-8E64-CC38C0955ECBQ33684746-87CA45C5-A444-4FE6-9856-796AAF7AC72EQ33737587-6B85DB72-AD4F-48DC-BF92-DDC8B10F5CB7Q34182397-C05229B7-9AF2-41DB-8AB5-E8C677466B39Q34357869-9AB0CA45-65EE-4E78-8A94-5DF90AD37F80Q34573600-9D92711B-CF2C-46B6-A038-734E30AD49B6Q34702075-75456D29-362F-46B5-9699-49DEAF7ED6D5Q34750730-8127F66C-404F-471E-96C0-7C408FC469A0Q35034000-3D242528-1FD1-4987-A0F2-0AFF5295D8D9Q35219502-02BADA2C-F210-4070-AE60-DEE84D9FDDD6Q35857794-EC4E9668-8FEA-43AB-81E4-F7EE8630B11EQ35878340-2D7728D2-B4F4-4CBD-B394-116D61B5F2D2Q36009618-6E17DAAE-4908-490C-B03F-12D463E72460Q36041024-4C5C8BEE-80DC-4F3F-8738-AF2E0F244626Q36090395-903702B3-CA39-4C64-B263-79211C0975CDQ36193534-4B377A4A-C720-4B4C-8CB1-F7217C6BD8CCQ36244683-5B9E8C97-6F18-4084-9B20-404FA923BD08Q36330126-FE1AA663-18CC-4E9D-A4A4-14F08AE0BFD2Q36395571-12A733CB-2AD8-4661-A7F0-8B4BB83FB268Q36400062-90966560-7B5F-4B59-AAE2-6359951735ECQ36558853-A64208D9-F05D-4746-B265-013912C3F9D1Q36701636-B1502E28-820D-4110-A75E-1216007931D1Q36702738-6871B81B-2257-4F97-AB36-2E65BBD5A7B1Q37008655-5BD055B6-CC24-4769-894C-A4DFFB812F52Q37109909-25C9A864-4614-4B88-B812-15CBADAC8F9AQ37116888-CD469EFB-8AC0-44B3-B628-834D7E62E23BQ37460268-C20949FF-CAE8-47C1-90B6-4814A9374F45Q37544748-3E6A13CF-8578-41BF-80A8-A822C9E1BFD1Q37669053-F129D1EE-AB29-4295-A6A8-F5BF61E042B6Q37869391-C9B5E9F8-111B-4170-8BAA-B1D97CD3FE9BQ37933151-1DB8AC9B-F8A2-4C1B-9B1E-033B12F2DFC0Q38042556-0A1F3DAE-101F-4222-90EA-F49BD9A23F52Q38120515-5BD9BC1D-A95A-492B-9FFA-8DAA2E88E5F8Q38125257-9AAA26E5-D24C-4D25-BFFD-60857617BE63Q38209925-5C2F6FAC-ADC0-4FD1-80DB-8F63FCC74BD7Q38472691-28DFE94B-46FD-434D-B2A7-4B71F25F2B60
P2860
Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Non-functional neuroendocrine ...... nd outcomes in 2,158 patients.
@en
Non-functional neuroendocrine ...... nd outcomes in 2,158 patients.
@nl
type
label
Non-functional neuroendocrine ...... nd outcomes in 2,158 patients.
@en
Non-functional neuroendocrine ...... nd outcomes in 2,158 patients.
@nl
prefLabel
Non-functional neuroendocrine ...... nd outcomes in 2,158 patients.
@en
Non-functional neuroendocrine ...... nd outcomes in 2,158 patients.
@nl
P2093
P1476
Non-functional neuroendocrine ...... nd outcomes in 2,158 patients.
@en
P2093
A James Moser
Elizabeth Genovese
Jan Franko
Linwah Yip
Wentao Feng
P2888
P304
P356
10.1007/S11605-009-1115-0
P577
2009-12-09T00:00:00Z